FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Mazur Leonard L
2. Date of Event Requiring Statement (Month/Day/Year)
09/12-06:00/2014
3. Issuer Name and Ticker or Trading Symbol
Citius Pharmaceuticals, Inc. [CTXR]
(Last)
(First)
(Middle)
C/O CITIUS PHARMACEUTICALS, INC., 63 GREAT ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
10/28-06:00/2015
(Street)

MAYNARD, MA 01754
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options to Purchase Common Stock   (1) 09/12-06:00/2024 Common Stock 1,500,000 $ 0.45 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Mazur Leonard L
C/O CITIUS PHARMACEUTICALS, INC.
63 GREAT ROAD
MAYNARD, MA 01754
  X      

Signatures

/s/ Leonard Mazur 04/12-06:00/2016
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On October 28, 2015, the Reporting Person filed a Form 3 with the Commission. The Form 3 included an option to purchase 1,300,000 shares of common stock of the Issuer (the "Common Stock"); however, the grant was for an option to purchase 3,300,000 shares of common Stock. Accordingly, the previously filed Form 3 omitted the option to purchase an additional 1,500,000 shares of Common Stock. The option to purchase an aggregate of 3,300,000 shares of Common Stock shall vest and become exercisable as follows: (i) the option to purchase 1,300,000 shares of Common Stock vested on September 12, 2014, (ii) the option to purchase 500,000 shares of Common Stock vested on September 12, 2015, (iii) the option to purchase 500,000 shares of Common Stock vested on March 12, 2016 (iv) the option to purchase 500,000 shares of Common Stock shall vest on September 12, 2016 and (v) the option to purchase 500,000 shares of Common Stock shall vest on September 12, 2017. The option was issued pursuant to the Company's 2014 Stock Incentive Plan.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.